A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Aug 2015
- 1667-77 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1569-8041
10.1093/annonc/mdv102 doi
Antibodies, Monoclonal, Murine-Derived--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use Bendamustine Hydrochloride--administration & dosage Cyclophosphamide--therapeutic use Doxorubicin--therapeutic use Humans Immunologic Factors--therapeutic use Lenalidomide Lymphoma, B-Cell--drug therapy Lymphoma, Follicular--drug therapy Lymphoma, Large B-Cell, Diffuse--drug therapy Lymphoma, Mantle-Cell--drug therapy Lymphoma, Non-Hodgkin--drug therapy Prednisone--therapeutic use Rituximab--administration & dosage Thalidomide--administration & dosage Treatment Outcome Vincristine--therapeutic use